Compounds > etidronate
Page last updated: 2024-10-26

etidronate and Endometrioma

etidronate has been researched along with Endometrioma in 4 studies

Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.

Endometrioma: An enlarged area of ENDOMETRIOSIS that resembles a tumor. It is usually found in the OVARY. When it is filled with old blood, it is known as a chocolate cyst.

Research Excerpts

ExcerptRelevanceReference
"To examine the safety and efficacy of combining cyclic sodium etidronate and low-dose norethindrone with a long-acting GnRH agonist (GnRH-a) for prolonged therapy of symptomatic endometriosis."9.08Prolonged gonadotropin-releasing hormone agonist treatment of symptomatic endometriosis: the role of cyclic sodium etidronate and low-dose norethindrone "add-back" therapy. ( Fournet, N; Judd, HL; Surrey, ES; Voigt, B, 1995)
"To examine the safety and efficacy of combining cyclic sodium etidronate and low-dose norethindrone with a long-acting GnRH agonist (GnRH-a) for prolonged therapy of symptomatic endometriosis."5.08Prolonged gonadotropin-releasing hormone agonist treatment of symptomatic endometriosis: the role of cyclic sodium etidronate and low-dose norethindrone "add-back" therapy. ( Fournet, N; Judd, HL; Surrey, ES; Voigt, B, 1995)
"These preliminary data suggest that the addition of cyclic sodium etidronate in combination with low-dose norethindrone to GnRH agonists is an effective means of ameliorating the hypoestrogenic side effects induced by GnRH agonist alone."2.67Effects of sodium etidronate in combination with low-dose norethindrone in patients administered a long-acting GnRH agonist: a preliminary report. ( Fournet, N; Judd, HL; Surrey, ES; Voigt, B, 1993)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's3 (75.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Paterson, CR1
Feely, J1
Surrey, ES2
Voigt, B2
Fournet, N2
Judd, HL2
Mukherjee, T1
Barad, D1
Turk, R1
Freeman, R1

Trials

3 trials available for etidronate and Endometrioma

ArticleYear
Prolonged gonadotropin-releasing hormone agonist treatment of symptomatic endometriosis: the role of cyclic sodium etidronate and low-dose norethindrone "add-back" therapy.
    Fertility and sterility, 1995, Volume: 63, Issue:4

    Topics: Adult; Bone Density; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administrat

1995
Effects of sodium etidronate in combination with low-dose norethindrone in patients administered a long-acting GnRH agonist: a preliminary report.
    Obstetrics and gynecology, 1993, Volume: 81, Issue:4

    Topics: Bone Density; Bone Resorption; Drug Therapy, Combination; Endometriosis; Estrogens; Etidronic Acid;

1993
A randomized, placebo-controlled study on the effect of cyclic intermittent etidronate therapy on the bone mineral density changes associated with six months of gonadotropin-releasing hormone agonist treatment.
    American journal of obstetrics and gynecology, 1996, Volume: 175, Issue:1

    Topics: Adult; Bone Density; Bone Remodeling; Double-Blind Method; Endometriosis; Estradiol; Etidronic Acid;

1996

Other Studies

1 other study available for etidronate and Endometrioma

ArticleYear
Vitamin D metabolites and analogues, diphosphonates, danazol, and bromocriptine.
    British medical journal (Clinical research ed.), 1983, May-21, Volume: 286, Issue:6378

    Topics: Acromegaly; Bromocriptine; Calcitriol; Danazol; Endometriosis; Etidronic Acid; Female; Fibrocystic B

1983